News ReleasesRSS
- Sep 20, 2019 Chugai Obtains Approval for Additional Indication and Formulation for Tecentriq in PD-L1-Positive Triple Negative Breast Cancer
- Sep 18, 2019 Chugai Selected for the Fifth Time and 2nd Consecutive Year for Dow Jones Sustainability Asia Pacific Index
- Sep 13, 2019 Chugai Receives Orphan Drug Designation for Satralizumab in Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder from the Ministry of Health, Labour and Welfare
- Sep 12, 2019 Chugai Presents Results from Second Positive Global Phase III Clinical Study of Satralizumab in NMOSD at ECTRIMS 2019
- Sep 09, 2019 Chugai’s Disease Awareness Website “Let’s Learn about Rheumatoid Arthritis” Adopts FACIL’iti to Enhanse Accessibility
What's NewRSS
- Sep 09, 2019 Webcast of Information Meeting on Rozlytrek®
- Sep 06, 2019 Summary of the Chugai CEO Meeting
- Sep 05, 2019 Information Meeting on Rozlytrek®
- Jul 29, 2019 Webcast of Investor Conference on FY2019 2Q Financial Results
- Jul 26, 2019 Investor Conference on FY2019 2Q Financial Results
Share price
Pick Up
For more information
Aiming to be a company where everyone can shine
Feature: Chugai’s Sustainability Activities
Recent Social Contribution Activities
-
Biology Lab Classes for Children Held (2018)
-
Participating in the 48th Annual Cleaning of the Famed Nihonbashi Bridge
-
Chugai to Take Part in Relay for Life Japan 2018
